Go Deep
Renascience Inc.
Renascience Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,790 | -40.8 | 4.18 | 0.00 | 595.07 |
Renascience Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 10,000,000.0 | 28,554,000.0 | 30,000,000.0 | 0.0 |
| Net Profit | -82,040,000.0 | -82,961,000.0 | -66,587,000.0 | -84,851,000.0 |
| EPS | -6.0 | — | — | — |
Renascience Inc. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 68,554,000.0 | 132,693,000.0 | 194,165,000.0 | 100,545,000.0 | — |
| Net Profit | -301,276,000.0 | 113,427,000.0 | -258,335,000.0 | -335,797,000.0 | — |
| EPS | -23.4 | 8.9 | -20.3 | -26.4 | — |
Renascience Inc. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 3,503,263,000.0 | 1,871,362,000.0 | 2,088,833,000.0 | 2,274,818,000.0 | — |
| Total Liabilities | 180,586,000.0 | 151,210,000.0 | 482,109,000.0 | 409,759,000.0 | — |
| Total Equity | 3,322,677,000.0 | 1,720,152,000.0 | 1,606,724,000.0 | 1,865,059,000.0 | — |
Owes vs Owns
Renascience Inc. owed ¥0.02 for every ¥1 it owned in Jun 2026, down from ¥0.18 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.02× | 0.05× | 0.08× | 0.23× | 0.18× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Renascience Inc. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 97.1%Other assets 2.9%
How it's funded — Mar 2026
Payables 4.4%Other liabilities 0.8%Shareholders' equity 94.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3,402.7 | 1,799.8 | 2,026.9 | 2,212.5 |
| Receivables | 0.0 | 0.0 | 4.4 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 4.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 100.5 | 71.5 | 57.5 | 57.9 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 356.1 | 309.6 |
| Payables | 154.3 | 144.6 | 123.4 | 97.7 |
| Other liabilities | 26.3 | 6.6 | 2.6 | 2.5 |
| Shareholders' equity | 3,322.7 | 1,720.2 | 1,606.7 | 1,865.1 |
| Net tangible assets | 3,322.7 | 1,720.2 | 1,606.7 | 1,864.9 |
Renascience Inc. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -291,307,000.0 | -176,342,000.0 | -230,519,000.0 | -284,641,000.0 | — |
| Investing Activities | 0.0 | 382,147,000.0 | -1,567,000.0 | 232,000.0 | — |
| Financing Activities | 1,894,196,000.0 | -52,182,000.0 | 46,500,000.0 | 110,371,000.0 | — |